| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | pac-1 | GDSC1000 | pan-cancer | AAC | 0.0097 | 0.8 |
| mRNA | itraconazole | CTRPv2 | pan-cancer | AAC | -0.01 | 0.8 |
| mRNA | BRD-K50799972 | CTRPv2 | pan-cancer | AAC | -0.01 | 0.8 |
| mRNA | PF-3758309 | CTRPv2 | pan-cancer | AAC | 0.011 | 0.8 |
| mRNA | TAE684 | CCLE | pan-cancer | AAC | -0.013 | 0.8 |
| mRNA | Compound 7d-cis | CTRPv2 | pan-cancer | AAC | -0.0096 | 0.8 |
| mRNA | MG-132 | CTRPv2 | pan-cancer | AAC | -0.015 | 0.8 |
| mRNA | alisertib:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.009 | 0.8 |
| mRNA | thapsigargin | GDSC1000 | pan-cancer | AAC | -0.0088 | 0.8 |
| mRNA | BRD-K99584050 | CTRPv2 | pan-cancer | AAC | 0.015 | 0.8 |